Ashley Siegel

Ashley Siegel has a strong background in research and development. Ashley started their career as a Postdoctoral Researcher at the Australian Regenerative Medicine Institute from January 2012 to July 2014. Ashley then joined Elemental Enzymes in August 2014 as a Senior Research Scientist, where they contributed their expertise until August 2015. Ashley Siegel was promoted to Vice President of Research and Development at Elemental Enzymes in August 2015 and held this role until January 2020. Currently, they are the Chief Science Officer at Elemental Enzymes, starting this position in February 2020.

Ashley Siegel earned a Bachelor of Science (BS) degree from Truman State University in the field of study that is not specified. This took place from 2000 to 2004. Following this, they pursued a Master of Science (MS) degree at Truman State University from 2004 to 2006, without specifying their field of study. Lastly, Ashley Siegel obtained a Doctor of Philosophy (PhD) degree in Developmental Biology and Embryology from the University of Missouri-Columbia, a program that they undertook from 2006 to 2011.